From October 1, 2022 to December 30, 2022, the company has repurchased 866,200 shares, representing 0.53% for CNY 19.07 million. With this, the company has completed the repurchase of 2,389,050 shares, representing 1.44% for CNY 50.02 million under the buyback announced on April 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.86 CNY | -3.14% |
|
-5.10% | -31.81% |
04-24 | Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-03 | Hvsen Biotechnology Co., Ltd. announced a financing transaction | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.81% | 222M | |
-13.41% | 77.98B | |
+22.35% | 9.01B | |
+23.12% | 3.64B | |
+13.01% | 1.65B | |
-5.08% | 1.23B | |
-30.18% | 1.16B | |
-31.11% | 1.15B | |
-23.45% | 999M | |
-11.41% | 926M |
- Stock Market
- Equities
- 300871 Stock
- News Hvsen Biotechnology Co., Ltd.
- Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.